Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases.
about
Echocardiographic diagnosis of the different phenotypes of hypertrophic cardiomyopathyAnimal and in silico models for the study of sarcomeric cardiomyopathiesRole of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology.Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: From Experiment to Standard of CareGenetic advances in sarcomeric cardiomyopathies: state of the art.Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy.Autophagic vacuoles in cardiomyocytes of dilated cardiomyopathy with initially decompensated heart failure predict improved prognosis.Diagnostic accuracy of standard axial 64-slice chest CT compared to cardiac MRI for the detection of cardiomyopathiesNatural History of Dilated Cardiomyopathy in ChildrenTargeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathyEnhancing the diagnosis of fabry disease in cardiology with a targeted information: a before-after control-impact study.Genetic biomarkers in hypertrophic cardiomyopathy.Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations.Role of non-invasive imaging in the work-up of cardiomyopathies.Cardiac amyloidosis: the great pretender.Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases.Current applications of biomarkers in cardiomyopathies.Nomenclature and systems of classification for cardiomyopathy in children.Misclassification of hypertrophic cardiomyopathy: validation of diagnostic codes.Whole gene sequencing identifies deep-intronic variants with potential functional impact in patients with hypertrophic cardiomyopathy.Genetics of hypertrophic cardiomyopathy: A review of current state.Multimodality imaging in restrictive cardiomyopathies: an EACVI expert consensus document: In collaboration with the 'Working Group on myocardial and pericardial diseases' of the European Society of Cardiology Endorsed by the Indian Academy of EchocSudden death risk stratification in non-ischemic dilated cardiomyopathy using old and new tools: a clinical challenge.Insights into mildly dilated cardiomyopathy: temporal evolution and long-term prognosis.Familial dilated cardiomyopathy. Clinical and genetic characteristics.Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy.Current state of the art and future of myectomy.Left ventricular non-compaction -challenges and controversies.Ultrastructural features of cardiomyocytes in dilated cardiomyopathy with initially decompensated heart failure as a predictor of prognosis.How is dilated cardiomyopathy investigated in Scotland? A contemporary survey.Return to work in heart failure patients with suspected viral myocarditis.Management of Bradyarrhythmias in Heart Failure: A Tailored Approach.The eyes are the window to the heart: one case of cardiac amyloidosis with eyelid swelling as the initial symptom.Feasibility and reproducibility of feature-tracking-based strain and strain rate measures of the left ventricle in different diseases and genders.Severe hypertrophic cardiomyopathy in a patient with atypical Anderson-Fabry disease.The PRKAG2 gene and hypertrophic cardiomyopathy: an energetically imbalanced relationship.The Role of Serum Adiponectin for Outcome Prediction in Patients with Dilated Cardiomyopathy and Advanced Heart Failure.Variable clinical presentation of glycogen storage disease type IV: from severe hepatosplenomegaly to cardiac insufficiency. Some discrepancies in genetic and biochemical abnormalities.Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: the importance of clinical context.Evolving concepts in dilated cardiomyopathy.
P2860
Q26741587-E14553B0-996C-42F1-BF69-CA193C98C977Q26865437-B9EECBDC-32ED-4C2D-92FB-FB2880B42CE5Q28069234-75C9E0F2-CEA4-4C39-9170-07D567F6AF5FQ33166450-8492C008-D360-4361-9143-4CA9FEC05009Q35145962-85B5813C-3900-44EB-9C09-1AD852128A93Q36559736-DD01D669-962A-4AEB-9E41-25B7B6E67AA0Q36810959-1333F05A-5FEA-4F5E-B3FB-5A7D146E7821Q37178893-7A65F88C-2D71-4A84-ABA9-A4FF8E20E8B6Q37240681-C3BAFCDD-91EC-4E0B-AA44-8DC60A8B71FBQ37269947-C9D640EF-8751-4FE6-B81E-A47D36D6C699Q37741698-05DA7D06-433D-41F8-9CCF-DFD3678401A5Q38125765-C7EC4A18-B956-44D6-B4C8-CA0A2E9ABAA0Q38336102-46A29B74-CE1E-4F41-92B7-89CB592579A4Q38338232-B347EB0C-D700-445A-8228-94A387ABA762Q38372860-47D9A980-B7E3-4A50-A3C9-4D2B0D09F216Q38418005-AE4F2786-A10E-4EAA-A5FA-1195C430375CQ38536678-587B6E6C-D20D-4634-8506-59C38EA30EE6Q38588152-42D5FC13-0211-4F99-8098-57255397D45CQ38604979-3820C27B-9090-425A-9818-1FD2EFB540C7Q38630261-465C2131-3519-49C9-A6C0-5EBCDA0C6A56Q38736063-F9DA9339-A005-4A62-9FF1-CD35C83900FCQ38782767-4A821981-8C5F-47A3-A982-7EF1ED2DAA2CQ39177912-53E4D2AA-A311-4446-8E11-3B3E03B0F19DQ39215730-E76E1CDC-93AB-4529-83ED-B0E8A8AA6740Q39506391-794DBC0D-BE78-4874-96C6-8A52E62E573FQ40503224-66581A63-FE08-41D2-99DC-14388BE7D195Q41698069-A4C878A2-D45C-4D99-9C6E-D065324F890CQ42028699-36AE1000-921F-480B-9184-AB72C030EB29Q43841215-B6B77053-CFC2-40E3-8265-D6340BFABFD7Q44542719-472B1C41-9FA2-4679-A3C7-EF4D86C8F637Q47138671-CA807378-3BC8-41E4-8138-115C8ACFEC27Q47217272-B7A9B23A-27A2-45CE-9A14-448B35548072Q47321246-511DB1F6-2DDA-402D-85F2-2EABFA4AAF8FQ47367797-EE7D8F58-6DB9-4D68-A269-001B5A0782FCQ47935620-524FDCDE-4533-4546-8713-A1CEA43ED518Q48261584-EB4406C0-E794-4106-B623-526DA798630AQ48275039-B0D26C63-C3EB-4EA5-A17E-F8B57C1606EFQ49578189-269AF9E5-E8A3-4F53-B50C-75109E0731DAQ50138783-378EA0C3-1979-4993-95CE-57C63FF60B87Q50167027-6D87F3EA-17A1-4167-8C39-6961749E9E9F
P2860
Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Diagnostic work-up in cardiomy ...... dial and Pericardial Diseases.
@en
Diagnostic work-up in cardiomy ...... dial and Pericardial Diseases.
@nl
type
label
Diagnostic work-up in cardiomy ...... dial and Pericardial Diseases.
@en
Diagnostic work-up in cardiomy ...... dial and Pericardial Diseases.
@nl
prefLabel
Diagnostic work-up in cardiomy ...... dial and Pericardial Diseases.
@en
Diagnostic work-up in cardiomy ...... dial and Pericardial Diseases.
@nl
P2093
P2860
P50
P356
P1476
Diagnostic work-up in cardiomy ...... dial and Pericardial Diseases.
@en
P2093
Alida L P Caforio
Arsen Ristic
Hubert Seggewiss
Jens Mogensen
Perry M Elliott
Tiina Heliö
Yigal Pinto
P2860
P304
P356
10.1093/EURHEARTJ/EHS397
P50
P577
2012-12-04T00:00:00Z